Deutsche Bank’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.09M | Sell |
282,792
-3,174,436
| -92% | -$45.5M | ﹤0.01% | 1402 |
|
|
2025
Q4 | $49.2M | Buy |
3,457,228
+976,630
| +39% | +$9.59M | 0.02% | 637 |
|
|
2025
Q3 | $19.5M | Buy |
2,480,598
+1,213,295
| +96% | +$8.63M | 0.01% | 862 |
|
|
2025
Q2 | $7.26M | Buy |
1,267,303
+228,313
| +22% | +$1.47M | ﹤0.01% | 1094 |
|
|
2025
Q1 | $8.48M | Buy |
1,038,990
+216,882
| +26% | +$2.01M | ﹤0.01% | 1051 |
|
|
2024
Q4 | $7.74M | Buy |
822,108
+87,491
| +12% | +$909K | ﹤0.01% | 1125 |
|
|
2024
Q3 | $7.85M | Sell |
734,617
-2,254,799
| -75% | -$24.6M | ﹤0.01% | 1102 |
|
|
2024
Q2 | $29.7M | Sell |
2,989,416
-1,361,665
| -31% | -$14M | 0.01% | 704 |
|
|
2024
Q1 | $51.3M | Sell |
4,351,081
-1,427,663
| -25% | -$18.3M | 0.02% | 544 |
|
|
2023
Q4 | $82M | Buy |
5,778,744
+5,632,116
| +3,841% | +$63.9M | 0.04% | 390 |
|
|
2023
Q3 | $1.78M | Sell |
146,628
-6,112,106
| -98% | -$78.8M | ﹤0.01% | 1405 |
|
|
2023
Q2 | $78.6M | Buy |
6,258,734
+5,151,461
| +465% | +$61.1M | 0.04% | 391 |
|
|
2023
Q1 | $12.3M | Buy |
1,107,273
+70,969
| +7% | +$875K | 0.01% | 901 |
|
|
2022
Q4 | $12.7M | Sell |
1,036,304
-523,256
| -34% | -$5.89M | 0.01% | 885 |
|
|
2022
Q3 | $16.3M | Sell |
1,559,560
-4,731,916
| -75% | -$52.7M | 0.01% | 819 |
|
|
2022
Q2 | $67.6M | Buy |
6,291,476
+641,299
| +11% | +$5.28M | 0.04% | 423 |
|
|
2022
Q1 | $53.5M | Sell |
5,650,177
-118,470
| -2% | -$1.11M | 0.03% | 557 |
|
|
2021
Q4 | $66.6M | Sell |
5,768,647
-1,348,747
| -19% | -$15M | 0.03% | 499 |
|
|
2021
Q3 | $68M | Sell |
7,117,394
-1,227,336
| -15% | -$12.6M | 0.03% | 493 |
|
|
2021
Q2 | $80.4M | Buy |
8,344,730
+1,030,803
| +14% | +$10.1M | 0.04% | 446 |
|
|
2021
Q1 | $72.3M | Buy |
7,313,927
+1,800,313
| +33% | +$27.9M | 0.04% | 451 |
|
|
2020
Q4 | $127M | Sell |
5,513,614
-491,838
| -8% | -$10.1M | 0.08% | 261 |
|
|
2020
Q3 | $84.8M | Sell |
6,005,452
-255,357
| -4% | -$3.72M | 0.06% | 301 |
|
|
2020
Q2 | $94.4M | Buy |
6,260,809
+2,139,554
| +52% | +$26.1M | 0.07% | 267 |
|
|
2020
Q1 | $38.1M | Buy |
4,121,255
+2,492,623
| +153% | +$23.7M | 0.03% | 441 |
|
|
2019
Q4 | $15.9M | Sell |
1,628,632
-4,007,053
| -71% | -$36.7M | 0.01% | 878 |
|
|
2019
Q3 | $45.2M | Sell |
5,635,685
-86,760
| -2% | -$942K | 0.03% | 512 |
|
|
2019
Q2 | $71.4M | Buy |
5,722,445
+3,205,378
| +127% | +$40.7M | 0.04% | 447 |
|
|
2019
Q1 | $34.2M | Buy |
2,517,067
+381,835
| +18% | +$4.66M | 0.02% | 736 |
|
|
2018
Q4 | $20.5M | Sell |
2,135,232
-431,480
| -17% | -$4.74M | 0.01% | 883 |
|
|
2018
Q3 | $31M | Buy |
2,566,712
+588,522
| +30% | +$8.23M | 0.02% | 886 |
|
|
2018
Q2 | $30.9M | Sell |
1,978,190
-841,204
| -30% | -$12.7M | 0.02% | 913 |
|
|
2018
Q1 | $42.4M | Buy |
2,819,394
+844,274
| +43% | +$12.8M | 0.02% | 719 |
|
|
2017
Q4 | $28.4M | Sell |
1,975,120
-341,668
| -15% | -$4.69M | 0.02% | 795 |
|
|
2017
Q3 | $34.9M | Buy |
2,316,788
+1,341,181
| +137% | +$17.7M | 0.02% | 700 |
|
|
2017
Q2 | $9.82M | Sell |
975,607
-75,111
| -7% | -$604K | 0.01% | 1417 |
|
|
2017
Q1 | $7.49M | Sell |
1,050,718
-74,305
| -7% | -$470K | 0.01% | 1432 |
|
|
2016
Q4 | $5.59M | Sell |
1,125,023
-229,804
| -17% | -$1.59M | ﹤0.01% | 1606 |
|
|
2016
Q3 | $10M | Buy |
1,354,827
+497,199
| +58% | +$3.36M | 0.01% | 1307 |
|
|
2016
Q2 | $4.68M | Buy |
857,628
+530,201
| +162% | +$3.71M | ﹤0.01% | 1810 |
|
|
2016
Q1 | $2.77M | Sell |
327,427
-441,825
| -57% | -$3.13M | ﹤0.01% | 2147 |
|
|
2015
Q4 | $7.46M | Buy |
769,252
+224,754
| +41% | +$2.03M | 0.01% | 1518 |
|
|
2015
Q3 | $7.62M | Buy |
544,498
+257,730
| +90% | +$4.04M | 0.01% | 1476 |
|
|
2015
Q2 | $4.06M | Sell |
286,768
-158,379
| -36% | -$1.9M | ﹤0.01% | 1943 |
|
|
2015
Q1 | $4.84M | Buy |
445,147
+72,976
| +20% | +$643K | ﹤0.01% | 1806 |
|
|
2014
Q4 | $3.1M | Buy |
372,171
+186,513
| +100% | +$1.28M | ﹤0.01% | 2330 |
|
|
2014
Q3 | $1.1M | Buy |
185,658
+39,443
| +27% | +$207K | ﹤0.01% | 2962 |
|
|
2014
Q2 | $487K | Buy |
146,215
+126,567
| +644% | +$297K | ﹤0.01% | 3483 |
|
|
2014
Q1 | $40K | Buy |
19,648
+13,704
| +231% | +$34.3K | ﹤0.01% | 4635 |
|
|
2013
Q4 | $13K | Sell |
5,944
-87,198
| -94% | -$191K | ﹤0.01% | 4836 |
|
|
2013
Q3 | $215K | Buy |
93,142
+61,746
| +197% | +$155K | ﹤0.01% | 4085 |
|
|
2013
Q2 | $72K | Buy |
+31,396
| New | +$96.5K | ﹤0.01% | 4372 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Deutsche Bank's FOLD Position: Q1 2026 in Review
Deutsche Bank reduced its Amicus Therapeutics (FOLD) stake by 92% in Q1 2026, selling an estimated $45.5M and leaving 282,792 shares worth $4.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.
Deutsche Bank first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. The position peaked at $127M in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Deutsche Bank held 282,792 shares of Amicus Therapeutics worth $4.09M as of Q1 2026.
- Deutsche Bank sold 3,174,436 Amicus Therapeutics shares in Q1 2026, an estimated $45.5M.
- Amicus Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1402 holding.
- Deutsche Bank first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Amicus Therapeutics position peaked at $127M in Q4 2020.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.